Autres langues Bio-Techne Corporation

Actions

TECH

US09073M1045

Temps réel estimé Cboe BZX Autres places de cotation 15:39:21 10/06/2024			Varia. 5j.	Varia. 1 janv.
76,63 ^USD	-1,29 %		+0,57 %	+0,61 %

06/06	Transcript : Bio-Techne Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:30 AM
04/06	Transcript : Bio-Techne Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 09:20 AM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES	03/06
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MAURICEFLEX SYSTEM AT THE ANNUAL ASMS CONFERENCE	31/05
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES	31/05
BIO-TECHNE CORPORATION - SCALEREADY ANNOUNCES $20 MILLION G-REX GRANT PROGRAM FOR THE ADVANCEMENT OF CELL AND GENE THERAPY DEVELOPMENT AND MANUFACTURING	30/05
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE	30/05
Bio-Techne Corporation to Showcase Multiple Applications of the MauriceFlex?? System at the Annual ASMS Conference	30/05
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing	29/05
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE	23/05
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY	22/05
Bio-Techne Corporation and Regulus Therapeutics Inc. Announces Continued Technical and Clinical Collaboration	22/05
Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing	16/05
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024	08/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Top Midday Gainers	01/05
US Equity Indexes Mixed as Investors Look for Clarity in Fed's Policy Path in Presidential Election Year	01/05
US Equity Indexes Mixed Ahead of Fed Policy Statement, Views on Monetary Policy Path for 2024	01/05
Bio-Techne Shares Jump After Fiscal Q3 Beat	01/05
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	01/05
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	01/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bio-Techne Corporation

Actions

TECH

US09073M1045

Autres langues

Filtres